{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:05:53Z","timestamp":1789117553768,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    Monocarboxylate transporter 8 (MCT8) deficiency, also known as Allan-Herndon-Dudley syndrome, is a rare X-linked disorder caused by pathogenic variants in the\n                    <jats:italic>SLC16A2<\/jats:italic>\n                    gene. It leads to impaired transport of thyroid hormones, particularly triiodothyronine (T3) and thyroxine (T4), across the blood-brain barrier and into neural cells. Consequently, the brain experiences reduced thyroid hormone availability, resulting in central hypothyroidism and severe neurodevelopmental impairment. In contrast, peripheral tissues remain exposed to elevated circulating T3, leading to chronic peripheral thyrotoxicosis. This review focuses on the effects of MCT8 deficiency beyond the neurological phenotype, with particular attention to liver involvement, skeletal muscle impairment, and hyperlactatemia. Current evidence suggests that peripheral organs are significantly affected by excess thyroid hormone signaling due to compensatory uptake through alternative thyroid hormone transporters. These alterations may contribute to metabolic disturbances and organ-specific manifestations that extend the clinical spectrum of the disease beyond the central nervous system. MCT8 deficiency should be considered a multisystem disorder rather than an isolated neurodevelopmental disease. Recognition of peripheral organ involvement may facilitate earlier diagnosis, improve clinical monitoring, and support the development of more targeted therapeutic strategies. Further research is needed to better understand the mechanisms underlying peripheral manifestations and their implications for patient care.\n                  <\/jats:p>","DOI":"10.3389\/fped.2026.1978653","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:07:07Z","timestamp":1789114027000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral manifestations of monocarboxylate transporter 8 deficiency: hepatic and skeletal muscle involvement"],"prefix":"10.3389","volume":"14","author":[{"given":"Lina","family":"Doeoes","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Endocrinology, Diabetology and Metabolism, Inselspital, University Hospital of Bern, University of Bern","place":["Bern, Switzerland"]},{"name":"University Institute of Clinical Chemistry, Inselspital, University Hospital of Bern, University of Bern","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Laemmle","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Endocrinology, Diabetology and Metabolism, Inselspital, University Hospital of Bern, University of Bern","place":["Bern, Switzerland"]},{"name":"University Institute of Clinical Chemistry, Inselspital, University Hospital of Bern, University of Bern","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"723750","DOI":"10.3389\/fendo.2021.723750","article-title":"Monocarboxylate transporter 8 deficiency: from pathophysiological understanding to therapy development","volume":"12","author":"Van Geest","year":"2021","journal-title":"Front Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00431-024-05931-7","article-title":"Clinical and genetic characteristics of patients with monocarboxylate transporter-8 deficiency: a multicentre retrospective study","volume":"184","author":"\u00c7elik","year":"2024","journal-title":"Eur J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.beem.2007.03.009","article-title":"The MCT8 thyroid hormone transporter and allan\u2013herndon\u2013dudley syndrome","volume":"21","author":"Schwartz","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"bnz008","DOI":"10.1210\/endrev\/bnz008","article-title":"Thyroid hormone transporters","volume":"41","author":"Groeneweg","year":"2020","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.beem.2007.03.003","article-title":"The importance of thyroid hormone transporters for brain development and function","volume":"21","author":"Heuer","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S2213-8587(20)30153-4","article-title":"Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study","volume":"8","author":"Groeneweg","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0139343","DOI":"10.1371\/journal.pone.0139343","article-title":"Further insights into the allan-herndon-dudley syndrome: clinical and functional characterization of a novel MCT8 mutation","volume":"10","author":"Armour","year":"2015","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1038\/s41467-025-56628-w","article-title":"Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration","volume":"16","author":"Groeneweg","year":"2025","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fnins.2020.00380","article-title":"MCT8 Deficiency: the road to therapies for a rare disease","volume":"14","author":"Grijota-Mart\u00ednez","year":"2020","journal-title":"Front Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1444919","DOI":"10.3389\/fped.2024.1444919","article-title":"Unmet patient needs in monocarboxylate transporter 8 (MCT8) deficiency: a review","volume":"12","author":"Bauer","year":"2024","journal-title":"Front Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/S0140-6736(04)17226-7","article-title":"Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation","volume":"364","author":"Friesema","year":"2004","journal-title":"Lancet"},{"key":"B12","author":"Friesema","year":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1089\/thy.2023.0467","article-title":"3,3\u2032,5-Triiodothyroacetic Acid transporters","volume":"34","author":"Chen","year":"2024","journal-title":"Thyroid\u00ae"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1089\/thy.2024.0285","article-title":"Combined levothyroxine and propylthiouracil treatment in children with monocarboxylate transporter 8 deficiency: a multicenter case series of 12 patients","volume":"34","author":"Weiss","year":"2024","journal-title":"Thyroid\u00ae"},{"key":"B15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1089\/thy.2022.0612","article-title":"Maternal administration of the CNS-selective sobetirome prodrug sob-AM2 exerts thyromimetic effects in murine MCT8-deficient fetuses","volume":"33","author":"Valc\u00e1rcel-Hern\u00e1ndez","year":"2023","journal-title":"Thyroid"},{"key":"B16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fendo.2018.00474","article-title":"Metabolic effects of the intracellular regulation of thyroid hormone: old players, new concepts","volume":"9","author":"Cicatiello","year":"2018","journal-title":"Front Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e40837","DOI":"10.1371\/journal.pone.0040837","article-title":"Effect of short-term thyroxine administration on energy metabolism and mitochondrial efficiency in humans","volume":"7","author":"Johannsen","year":"2012","journal-title":". PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/cells11060997","article-title":"Bioenergetic aspects of mitochondrial actions of thyroid hormones","volume":"11","author":"Cioffi","year":"2022","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/nyas.12374","article-title":"Thyroid hormone signaling in energy homeostasis and energy metabolism","volume":"1311","author":"McAninch","year":"2014","journal-title":"Ann New York Acad Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1172\/JCI200111775","article-title":"Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle","volume":"108","author":"Lebon","year":"2001","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1432-1033.1988.tb14477.x","article-title":"Altered relationship between protonmotive force and respiration rate in non-phosphorylating liver mitochondria isolated from rats of different thyroid hormone status","volume":"178","author":"Hafner","year":"1988","journal-title":"Eur J Biochem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrendo.2013.238","article-title":"Thyroid hormones and skeletal muscle\u2014new insights and potential implications","volume":"10","author":"Salvatore","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00237","article-title":"Regulation of skeletal muscle mitochondrial activity by thyroid hormones: focus on the \u201cold\u201d triiodothyronine and the \u201cemerging\u201d 3,5-diiodothyronine","volume":"6","author":"Lombardi","year":"2015","journal-title":"Front Physiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/thy.2007.0256","article-title":"Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle","volume":"18","author":"Simonides","year":"2008","journal-title":"Thyroid"},{"key":"B26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3275\/7754","article-title":"Iodothyronine deiodinases and cancer","volume":"34","author":"Piekie\u0142ko-Witkowska","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1210\/en.2005-0739","article-title":"Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice","volume":"147","author":"Schneider","year":"2006","journal-title":"Endocrinology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1210\/en.2011-1210","article-title":"The thyroid hormone-inactivating type III deiodinase is expressed in mouse and human \u03b2-cells and its targeted inactivation impairs insulin secretion","volume":"152","author":"Medina","year":"2011","journal-title":"Endocrinology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/j.2040-4603.2016.tb00708.x","article-title":"Hypothalamus-pituitary-thyroid axis","volume":"6","author":"Ortiga-Carvalho","year":"2016","journal-title":"Comprehens Physiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000596","article-title":"Thyroid hormone and the liver","volume":"9","author":"Soares De Oliveira","year":"2025","journal-title":"Hepatol Commun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.85.16.5804","article-title":"Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone","volume":"85","author":"Mitsuhashi","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","author":"Williams","year":""},{"key":"B34","doi-asserted-by":"publisher","first-page":"e240286","DOI":"10.1530\/ETJ-24-0286","article-title":"Toward a treatment for thyroid hormone transporter MCT8 deficiency\u2014achievements and challenges","volume":"13","author":"Markova","year":"2024","journal-title":"Eur Thyroid J"},{"key":"B35","first-page":"325","article-title":"Family with sex-linked idiocy","volume":"48","author":"Allan","year":"1944","journal-title":"Am J Mental Defic"},{"key":"B36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s12020-020-02603-y","article-title":"Monocarboxylate transporter 8 deficiency: update on clinical characteristics and treatment","volume":"71","author":"Van Geest","year":"2021","journal-title":"Endocrine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1210\/jc.2012-2556","article-title":"Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency","volume":"97","author":"Verge","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mce.2010.01.016","article-title":"Genetics and phenomics of thyroid hormone transport by MCT8","volume":"322","author":"Friesema","year":"2010","journal-title":"Mole Cell Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/thy.2020.0306","article-title":"Prenatal treatment of thyroid hormone cell membrane transport defect caused by MCT8 gene mutation","volume":"31","author":"Refetoff","year":"2021","journal-title":"Thyroid"},{"key":"B40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S2213-8587(19)30155-X","article-title":"Effectiveness and safety of the tri-iodothyronine analogue triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial","volume":"7","author":"Groeneweg","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4274\/jcrpe.galenos.2023.2023-10-1","article-title":"Impact of early intervention with triiodothyroacetic acid on peripheral and neurodevelopmental findings in a boy with MCT8 deficiency","volume":"16","author":"\u00dcnsal","year":"2024","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e1136","DOI":"10.1210\/clinem\/dgab750","article-title":"Long-term efficacy of t3 analogue triac in children and adults with MCT8 deficiency: a real-life retrospective cohort study","volume":"107","author":"van Geest","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1210\/clinem\/dgae146","article-title":"Glycerol phenylbutyrate treatment of 2 patients with monocarboxylate transporter 8 deficiency","volume":"109","author":"Zung","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.beem.2007.03.008","article-title":"Thyroid hormone transport by monocarboxylate transporters","volume":"21","author":"Visser","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1210\/en.2011-1166","article-title":"Identification and functional characterization of zebrafish solute carrier Slc16a2 (Mct8) as a thyroid hormone membrane transporter","volume":"152","author":"Arjona","year":"2011","journal-title":"Endocrinology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0004-27302011000100001","article-title":"Tissue-specific effects of mutations in the thyroid hormone transporter MCT8","volume":"55","author":"Kersseboom","year":"2011","journal-title":"Arq Bras Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000492129","article-title":"Effect of thyroid hormones on neurons and neurodevelopment","volume":"90","author":"Prezioso","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00431-007-0589-6","article-title":"Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter","volume":"167","author":"Namba","year":"2008","journal-title":"Eur J Pediatr"},{"key":"B49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"100455","DOI":"10.1016\/j.xhgg.2025.100455","article-title":"The phenotypic spectrum of individuals with SLC16A2 variants in MCT8 deficiency","volume":"6","author":"McWalter","year":"2025","journal-title":"Human Genet Genom Adv"},{"key":"B51","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/pr.119.018762","article-title":"Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease","volume":"72","author":"Felmlee","year":"2020","journal-title":"Pharmacol Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12864-025-11307-4","article-title":"The interactions between monocarboxylate transporter genes MCT1, MCT2, and MCT4 and the kinetics of blood lactate production and removal after high-intensity efforts in elite males: a cross-sectional study","volume":"26","author":"Maculewicz","year":"2025","journal-title":"BMC Genomics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/ten.tea.2019.0118","article-title":"Engineering tissues from induced pluripotent stem cells","volume":"25","author":"Loskill","year":"2019","journal-title":"Tissue Eng Part A"},{"key":"B54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrm.2016.8","article-title":"A decade of transcription factor-mediated reprogramming to pluripotency","volume":"17","author":"Takahashi","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1161\/ATVBAHA.117.309962","article-title":", evaluation, and application of human induced pluripotent stem cell\u2013derived endothelial cells","volume":"37","author":"Lin","year":"2017","journal-title":"Arterioscler Thromb Vasc Bio"},{"key":"B56","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbalip.2014.05.010","article-title":"Disease modeling using human induced pluripotent stem cells: lessons from the liver","volume":"1851","author":"Gieseck","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B57","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e4370","DOI":"10.7717\/peerj.4370","article-title":"Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications","volume":"6","author":"Omole","year":"2018","journal-title":"PeerJ"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1978653\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:07:08Z","timestamp":1789114028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1978653\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":58,"alternative-id":["10.3389\/fped.2026.1978653"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1978653","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1978653"}}